JP Morgan Maintains Neutral on Doximity, Raises Price Target to $31
Doximity, Inc. Class A
Doximity, Inc. Class A DOCS | 0.00 |
JP Morgan analyst Alexei Gogolev maintains Doximity (NYSE:
DOCS) with a Neutral and raises the price target from $26 to $31.
